Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Research and medical products | 26,642.0 | 24,802.0 | 17,979.0 | 13,512.0 | 12,686.0 | 11,512.4 | 10,366.7 | 8,110.9 |
| All other | 12,643.0 | 12,713.0 | 9,742.0 | 7,930.0 | 7,663.0 | 7,082.0 | 6,756.6 | 5,675.6 |
| Analytical & physical instrumentation | 2,846.0 | 2,620.0 | 2,443.0 | 2,464.0 | 2,437.0 | 2,232.9 | 2,088.9 | 2,014.4 |
| Product identification | 1,983.0 | 2,031.0 | 1,862.0 | 1,935.0 | 1,926.0 | 1,773.5 | 1,641.4 | 1,571.6 |
| Total revenues | 31,471.0 | 29,453.0 | 22,284.0 | 17,911.0 | 17,049.0 | 15,518.8 | 16,882.4 | 14,433.7 |
| Revenue growth [+] | 6.9% | 32.2% | 24.4% | 5.1% | 9.9% | -8.1% | 17.0% | 12.2% |
| Research and medical products | 7.4% | 37.9% | 33.1% | 6.5% | 10.2% | 11.1% | 27.8% | |
| All other | -0.6% | 30.5% | 22.8% | 3.5% | 8.2% | 4.8% | 19.0% | 6.9% |
| Analytical & physical instrumentation | 8.6% | 7.2% | -0.9% | 1.1% | 9.1% | 6.9% | 3.7% | 2.4% |
| Product identification | -2.4% | 9.1% | -3.8% | 0.5% | 8.6% | 8.0% | 4.4% | -2.5% |
| Cost of goods sold | 12,522.0 | 11,501.0 | 9,809.0 | 7,927.0 | 7,544.0 | 6,947.5 | 7,547.8 | 6,662.6 |
| Gross profit | 18,949.0 | 17,952.0 | 12,475.0 | 9,984.0 | 9,505.0 | 8,571.3 | 9,334.6 | 7,771.1 |
| Gross margin | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.2% | 55.3% | 53.8% |
| Selling, general and administrative | 8,516.0 | 8,198.0 | 6,896.0 | 5,589.0 | 5,391.0 | 5,042.6 | 5,624.3 | 4,747.5 |
| Research and development | 1,745.0 | 1,742.0 | 1,348.0 | 1,126.0 | 1,059.0 | 956.4 | 975.1 | 861.4 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | | 547.0 | | | | | | |
| EBITDA [+] | 10,910.0 | 9,633.0 | 6,006.0 | 4,458.0 | 4,233.0 | 3,689.2 | 3,863.3 | 3,043.0 |
| EBITDA growth | 13.3% | 60.4% | 34.7% | 5.3% | 14.7% | -4.5% | 27.0% | 10.1% |
| EBITDA margin | 34.7% | 32.7% | 27.0% | 24.9% | 24.8% | 23.8% | 22.9% | 21.1% |
| Depreciation | 738.0 | 718.0 | 637.0 | 564.0 | 562.0 | 537.9 | 545.1 | 483.8 |
| EBITA | 10,172.0 | 8,915.0 | 5,369.0 | 3,894.0 | 3,671.0 | 3,151.3 | 3,318.2 | 2,559.2 |
| EBITA margin | 32.3% | 30.3% | 24.1% | 21.7% | 21.5% | 20.3% | 19.7% | 17.7% |
| Amortization of intangibles | 1,484.0 | 1,450.0 | 1,138.0 | 625.0 | 616.0 | 579.0 | 583.0 | 397.0 |
| EBIT [+] | 8,688.0 | 7,465.0 | 4,231.0 | 3,269.0 | 3,055.0 | 2,572.3 | 2,735.2 | 2,162.2 |
| EBIT growth | 16.4% | 76.4% | 29.4% | 7.0% | 18.8% | -6.0% | 26.5% | 5.7% |
| EBIT margin | 27.6% | 25.3% | 19.0% | 18.3% | 17.9% | 16.6% | 16.2% | 15.0% |
| Interest expense, net [+] | 170.0 | 227.0 | 204.0 | -31.0 | 128.0 | 132.6 | 184.2 | 135.2 |
| Interest expense | 211.0 | 238.0 | 275.0 | 108.0 | 137.0 | 140.1 | 184.4 | 139.8 |
| Interest income | 41.0 | 11.0 | 71.0 | 139.0 | 9.0 | 7.5 | 0.2 | 4.6 |
| Other income (expense), net [+] | -226.0 | 360.0 | 468.0 | 5.0 | 35.0 | 103.5 | 60.3 | 12.4 |
| Gain (loss) on debt retirement | | -96.0 | -26.0 | -7.0 | | | -178.8 | |
| Other non-operating income | | | 5.0 | | | 103.5 | 239.1 | 12.4 |
| Other | -226.0 | 456.0 | 494.0 | 12.0 | 35.0 | -103.5 | -239.1 | -12.4 |
| Pre-tax income | 8,292.0 | 7,598.0 | 4,495.0 | 3,305.0 | 2,962.0 | 2,543.2 | 2,611.3 | 2,039.4 |
| Income taxes | 1,083.0 | 1,251.0 | 849.0 | 873.0 | 556.0 | 371.0 | 457.9 | 292.7 |
| Tax rate | 13.1% | 16.5% | 18.9% | 26.4% | 18.8% | 14.6% | 17.5% | 14.4% |
| Earnings from continuing ops | 7,103.0 | 6,269.0 | 3,510.0 | 2,351.0 | 2,406.0 | 2,172.2 | 2,153.4 | 1,746.7 |
| Earnings from discontinued ops | | | | 589.0 | 245.0 | 319.9 | 400.3 | 1,610.7 |
| Net income | 7,103.0 | 6,269.0 | 3,510.0 | 2,940.0 | 2,651.0 | 2,492.1 | 2,553.7 | 3,357.4 |
| Net margin | 22.6% | 21.3% | 15.8% | 16.4% | 15.5% | 16.1% | 15.1% | 23.3% |
| |
| Basic EPS [+] | $9.80 | $8.77 | $4.97 | $3.29 | $3.43 | $3.12 | $3.12 | $2.50 |
| Growth | 11.7% | 76.5% | 51.2% | -4.3% | 10.0% | 0.2% | 24.5% | 7.2% |
| Diluted EPS [+] | $9.64 | $8.51 | $4.88 | $3.24 | $3.39 | $3.08 | $3.08 | $2.47 |
| Growth | 13.3% | 74.2% | 50.7% | -4.3% | 10.1% | 0.0% | 24.8% | 7.7% |
| |
| Dividends per share [+] | $1.13 | $1.04 | $0.87 | $0.74 | $0.62 | $0.54 | $0.58 | $0.51 |
| Growth | 8.6% | 19.2% | 18.2% | 19.3% | 13.7% | -6.0% | 14.0% | 56.4% |
| |
| Shares outstanding (basic) [+] | 725.1 | 714.6 | 706.2 | 715.0 | 700.6 | 695.8 | 691.2 | 698.1 |
| Growth | 1.5% | 1.2% | -1.2% | 2.1% | 0.7% | 0.7% | -1.0% | -0.6% |
| Shares outstanding (diluted) [+] | 737.1 | 736.8 | 718.7 | 725.5 | 710.2 | 706.1 | 699.8 | 708.5 |
| Growth | 0.0% | 2.5% | -0.9% | 2.2% | 0.6% | 0.9% | -1.2% | -1.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|